Omata, MasaoMasaoOmataDan, YoshiyukiYoshiyukiDanDaniele, BrunoBrunoDanielePlentz, RubenRubenPlentzRudolph, Karl LenhardKarl LenhardRudolphManns, MichaelMichaelMannsPiratvisuth, TeerhaTeerhaPiratvisuthDING-SHINN CHENTateishi, RyosukeRyosukeTateishiChutaputti, AnuchitAnuchitChutaputti2018-09-102018-09-102002https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036106513&doi=10.1046%2fj.1440-1746.17.s1.14.x&partnerID=40&md5=de465c32aa1286d2c21d1892248dab98http://scholars.lib.ntu.edu.tw/handle/123456789/298701[SDGs]SDG3aminotransferase; antineoplastic agent; age distribution; artificial embolism; cancer diagnosis; cancer epidemiology; cancer patient; cancer size; cancer staging; cancer surgery; cancer survival; clinical feature; conference paper; geographic distribution; human; liver cell carcinoma; liver function test; multimodality cancer therapy; priority journal; prognosis; scoring systemClinical features, etiology, and survival of hepatocellular carcinoma among different countriesjournal article10.1046/j.1440-1746.17.s1.14.x